Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
$6.29
-0.6%
$7.44
$3.81
$37.50
$10.41M0.1711,769 shs65,899 shs
Nephros Inc. stock logo
NEPH
Nephros
$4.26
+1.2%
$3.82
$1.36
$5.00
$44.63M1.2342,731 shs30,254 shs
NeuroOne Medical Technologies Corporation stock logo
NMTC
NeuroOne Medical Technologies
$0.89
-0.6%
$0.80
$0.40
$1.39
$44.72M0.68377,789 shs459,913 shs
WOK
WORK Medical Technology Group
$0.80
-0.2%
$0.79
$0.36
$8.45
$45.67MN/A42,800 shs10,184 shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
-0.63%-8.18%-13.72%-44.53%-53.13%
Nephros Inc. stock logo
NEPH
Nephros
+1.19%+11.23%+3.40%+10.08%+125.99%
NeuroOne Medical Technologies Corporation stock logo
NMTC
NeuroOne Medical Technologies
-0.58%+12.15%+3.41%+58.20%+9.77%
WOK
WORK Medical Technology Group
+0.25%+2.56%+2.50%+1.27%-83.57%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
$6.29
-0.6%
$7.44
$3.81
$37.50
$10.41M0.1711,769 shs65,899 shs
Nephros Inc. stock logo
NEPH
Nephros
$4.26
+1.2%
$3.82
$1.36
$5.00
$44.63M1.2342,731 shs30,254 shs
NeuroOne Medical Technologies Corporation stock logo
NMTC
NeuroOne Medical Technologies
$0.89
-0.6%
$0.80
$0.40
$1.39
$44.72M0.68377,789 shs459,913 shs
WOK
WORK Medical Technology Group
$0.80
-0.2%
$0.79
$0.36
$8.45
$45.67MN/A42,800 shs10,184 shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
-0.63%-8.18%-13.72%-44.53%-53.13%
Nephros Inc. stock logo
NEPH
Nephros
+1.19%+11.23%+3.40%+10.08%+125.99%
NeuroOne Medical Technologies Corporation stock logo
NMTC
NeuroOne Medical Technologies
-0.58%+12.15%+3.41%+58.20%+9.77%
WOK
WORK Medical Technology Group
+0.25%+2.56%+2.50%+1.27%-83.57%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
2.00
Hold$100.001,489.83% Upside
Nephros Inc. stock logo
NEPH
Nephros
3.00
Buy$5.5029.11% Upside
NeuroOne Medical Technologies Corporation stock logo
NMTC
NeuroOne Medical Technologies
3.00
Buy$2.23150.25% Upside
WOK
WORK Medical Technology Group
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest LYRA, WOK, NEPH, and NMTC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/9/2025
NeuroOne Medical Technologies Corporation stock logo
NMTC
NeuroOne Medical Technologies
Maxim Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$3.00
8/14/2025
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingNeutral
8/8/2025
Nephros Inc. stock logo
NEPH
Nephros
Maxim Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$4.50 ➝ $6.00
(Data available from 9/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
$770K13.44N/AN/A$8.86 per share0.71
Nephros Inc. stock logo
NEPH
Nephros
$14.16M3.19$0.02 per share210.38$0.81 per share5.26
NeuroOne Medical Technologies Corporation stock logo
NMTC
NeuroOne Medical Technologies
$6.63M6.71N/AN/A$0.03 per share29.64
WOK
WORK Medical Technology Group
$11.51M3.96N/AN/A$1.10 per share0.73
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
-$93.43M-$29.01N/AN/AN/A-5,043.64%-404.56%-60.06%11/11/2025 (Estimated)
Nephros Inc. stock logo
NEPH
Nephros
$70K$0.1235.50N/A7.95%14.89%11.64%11/6/2025 (Estimated)
NeuroOne Medical Technologies Corporation stock logo
NMTC
NeuroOne Medical Technologies
-$12.32M-$0.15N/AN/A-55.44%-163.49%-78.67%N/A
WOK
WORK Medical Technology Group
-$3.49MN/A0.00N/AN/AN/AN/AN/A

Latest LYRA, WOK, NEPH, and NMTC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/14/2025Q3 2025
NeuroOne Medical Technologies Corporation stock logo
NMTC
NeuroOne Medical Technologies
-$0.05-$0.03+$0.02-$0.03$1.82 million$1.70 million
8/12/2025Q2 2025
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
-$5.79-$5.51+$0.28-$5.51$0.18 million$0.29 million
8/7/2025Q2 2025
Nephros Inc. stock logo
NEPH
Nephros
-$0.0250$0.02+$0.0450$0.02$3.60 million$4.40 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
N/AN/AN/AN/AN/A
Nephros Inc. stock logo
NEPH
Nephros
N/AN/AN/AN/AN/A
NeuroOne Medical Technologies Corporation stock logo
NMTC
NeuroOne Medical Technologies
N/AN/AN/AN/AN/A
WOK
WORK Medical Technology Group
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
N/A
2.78
2.78
Nephros Inc. stock logo
NEPH
Nephros
N/A
5.41
4.14
NeuroOne Medical Technologies Corporation stock logo
NMTC
NeuroOne Medical Technologies
N/A
7.13
5.80
WOK
WORK Medical Technology Group
N/A
1.14
0.98

Institutional Ownership

CompanyInstitutional Ownership
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
95.62%
Nephros Inc. stock logo
NEPH
Nephros
41.10%
NeuroOne Medical Technologies Corporation stock logo
NMTC
NeuroOne Medical Technologies
16.07%
WOK
WORK Medical Technology Group
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
501.65 million1.59 millionOptionable
Nephros Inc. stock logo
NEPH
Nephros
3010.60 million9.89 millionNot Optionable
NeuroOne Medical Technologies Corporation stock logo
NMTC
NeuroOne Medical Technologies
2050.00 million45.55 millionOptionable
WOK
WORK Medical Technology Group
22657.00 millionN/AN/A

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Lyra Therapeutics stock logo

Lyra Therapeutics NASDAQ:LYRA

$6.29 -0.04 (-0.63%)
Closing price 09/12/2025 03:59 PM Eastern
Extended Trading
$6.59 +0.30 (+4.77%)
As of 09/12/2025 07:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Lyra Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained periods with a single administration. The company's product candidates include LYR-210, an anti-inflammatory implantable drug matrix for the treatment of chronic rhinosinusitis (CRS), which is in Phase III clinical trial; and LYR-220 for CRS patients with and without nasal polyps. It has a collaboration agreement with LianBio Inflammatory Limited to develop and commercialize LYR-210 in mainland China, Hong Kong, Taiwan, Macau, South Korea, Singapore, and Thailand. The company was formerly known as 480 Biomedical, Inc. and changed its name to Lyra Therapeutics, Inc. in July 2018. Lyra Therapeutics, Inc. was incorporated in 2005 and is headquartered in Watertown, Massachusetts.

Nephros stock logo

Nephros NASDAQ:NEPH

$4.26 +0.05 (+1.19%)
Closing price 09/12/2025 03:57 PM Eastern
Extended Trading
$4.23 -0.03 (-0.70%)
As of 09/12/2025 05:26 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Nephros, Inc., a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water, as well as reduce biofilm, cysts, particulates, and scale build-up in downstream equipment. It markets its products to food service, hospitality, convenience store, and health care markets, as well as medical institutions. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.

NeuroOne Medical Technologies stock logo

NeuroOne Medical Technologies NASDAQ:NMTC

$0.89 -0.01 (-0.58%)
Closing price 09/12/2025 04:00 PM Eastern
Extended Trading
$0.89 +0.00 (+0.10%)
As of 09/12/2025 07:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NeuroOne Medical Technologies Corporation, a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders. It also fucuses on applications for other areas, such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator. The company was incorporated in 2009 and is based in Eden Prairie, Minnesota.

WORK Medical Technology Group NASDAQ:WOK

$0.80 0.00 (-0.16%)
Closing price 09/12/2025 02:51 PM Eastern
Extended Trading
$0.80 0.00 (0.00%)
As of 09/12/2025 05:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

WORK Medical Technology Group Ltd. engages in developing health instruments. It manufactures and sells medical devices, including endotracheal tubes, laryngeal mask airways, heat and moisture exchanging filters, disposable breathing circuits, nebulizer kits, and yankauer suction sets. The company was founded on March 1, 2022 and is headquartered in Hangzhou, China.